Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSurvival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis
Cancer Chemotherapy and Pharmacology, 10/15/09
Lee SJ et al. – The ovarian metastatectomy significantly prolonged survival in CRC patients with ovarian metastases. The potential role of an ovarian metastatectomy in the management of CRC should be prospectively studied.
Methods- Between 1996 and 2008, 83 CRC patients underwent oophorectomy
- 47 CRC patients with ovarian metastasis without resection were included in analysis
- Median age was younger (48 years) in oophorectomy group compared with historical control
- Proportion of synchronous metastasis higher in oophorectomy group than in control group
- After a median follow-up duration of 60.8 months median OS significantly longer in oophorectomy group
- For ovary-specific survival (date of ovarian metastasis diagnosis to death), CRC patients with oophorectomy showed significantly more favorable survival rate than control group
- In univariate analyses, oophorectomy , unilaterality of ovarian metastasis , metastasis confined to ovaries , normal CEA level , good performance status , palliative chemotherapy (P = 0.001), and primary disease resection identified as significantly good prognostic factors for overall survival
- Oophorectomy, chemotherapy, metastasis confined to ovaries, normal CEA level, and good performance status retained statistical significance at multivariate level
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor
Human Pathology, 12/16/09
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
Carcinogenesis, 12/16/09
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication
American Journal of Medical Genetics, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor